News Column

PDL BIOPHARMA, INC. FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

August 8, 2014



Item 8.01 Other Events.

On August 8, 2014, PDL BioPharma, Inc. issued a press release announcing a delay in filing its Quarterly Report on Form 10-Q and a change in the date of its earnings release. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Cautionary Statements



This filing and the press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Important factors that could impair the value of the Company's royalty assets, restrict or impede the ability of the Company to invest in new royalty bearing assets and limit the Company's ability to pay dividends are disclosed in the risk factors contained in the Company's Annual Report on Form 10-K, as updated by subsequent quarterly reports, filed with the Securities and Exchange Commission. All forward-looking statements are expressly qualified in their entirety by such factors. We do not undertake any duty to update any forward-looking statement except as required by law.

Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description 99.1 Press Release



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters